loading   Loading page...

31 January 2019,
Nobel Forum, Stockholm

Disease mechanisms in schizophrenia –

novel discoveries and implications for clinical treatment

This scientific meeting has been financially supported by Sunovion Pharmaceuticals Europe Ltd. (SPE).
There has been no influence from Sunovion on the agenda and/or content of the meeting.

Schizophrenia is a devastating disorder where current treatment is only symptomatic and unsatisfactory.
Here, we will discuss the most recent findings from research on disease mechanisms, and how these can be translated into new treatment approaches that can modify the disease course.

Programme overview

08:30  Registration and coffee
09:00  Scientific programme starts
11:45  Lunch
12:45  Scientific programme
17:00  Programme closes

>>Detailed programme (pdf)

Keynote speakers

- Professor Ole Andreassen, Oslo, Norway
- Professor Iris E. Sommer, Groningen, Netherlands
- Professor Gregers Wegener, Aarhus, Denmark


Nobel Forum, is located at Karolinska Institutet Campus Solna, address: Nobels väg 1.

For finding the way, please see ki.se >>ki.se/om-ki/kontakta-och-besok-karolinska-institutet


The symposium is free of charge. Coffee and lunch is included. There is a limited number of seats available.

To register for the symposium, please go to:

>>Link to registration form


This meeting is organised by researchers at Karolinska Institutet that are active within the Karolinska Schizophrenia Project

- Associate professor Simon Cervenka
  Dept of Clinical Neuroscience
- Professor Göran Engberg
  Dept of Physiology and Pharmacology
- Professor Sophie Erhardt
  Dept of Physiology and Pharmacology